Browse the full record of transactions filed by 신종길, Directeur Exécutif. Officer active across 2 companies, notably 온코닉테라퓨틱스. In total, 17,943 disclosures have been recorded. History available since 4 March 2026. The latest transaction was filed on 4 March 2026 (Purchase). Regulator: DART (FSS). The full history is accessible without signup.
Shin Jong-gil is an Executive Director at Onconic Therapeutics. He is responsible for the strategic direction of the company and overseeing operations. His expertise in the biotechnology field allows him to guide the company in developing innovative therapeutic solutions. He plays a crucial role in achieving the company's objectives.